Wall Street Journal- Venture Capital Dispatch, Sept. 15, 2011

//Wall Street Journal- Venture Capital Dispatch, Sept. 15, 2011

Wall Street Journal- Venture Capital Dispatch, Sept. 15, 2011

The Push from Venture Capital Investors

Venture capital investors are keeping a close eye on the FDA, especially since the way it approves medical devices may be changing. Not only are they watching, they are involved in pushing for reforms. The Medical Innovation and Competitiveness Coalition (MedIC) is one of two organizations along with the Medical Device Venture Council (MDVC) which says, according to this Wall Street Journal article, a “risk-averse culture at the FDA that has been stifling innovation and driving jobs overseas.”

Read the rest of the article here.

 

By | 2011-09-16T21:17:36+00:00 September 16th, 2011|Media Reports|0 Comments

About the Author:

I’m National News Editor, Jane Akre and I began Mesh Medical Device News Desk aka Mesh News Desk (MND) in the summer of 2011 just after the Food and Drug Administration issued an explicit warning to the public that complications associated with surgical mesh used for prolapse repair (POP) and incontinence (SUI) are NOT rare! That was the starting point for the litigation you see today and thousands of lawsuits have been filed by women whose lives have been altered, some permanently, by the use of this petroleum-based product.

Leave A Comment

Interested in our free Mesh webinar? Learn More
Webinar Starts